Clinical Decision Support Systems (CDSS) Market by Component (Services, Software), Delivery (On-premise, Cloud), Product (Standalone, Integrated), Application (Advanced, Therapeutic, Diagnostic), Interactivity (Active, Passive) - Global Forecasts to 2028
The global clinical decision support systems (CDSS) market is projected to reach USD 2.5 billion by 2028 from USD 1.7 billion in 2023, at a CAGR of 7.5% during the forecast period. The growth of this market is primarily driven by the implementation of government regulations and initiatives to promote the adoption of HIT solutions, increasing adoption of CDSS-enabled EHRs, growing collaborations and partnerships between stakeholders, rising incidence of medication errors, and the development mHealth and big data tools.
However, high investment requirements for the implementation of CDSS and inadequate interoperability coupled with rising data security concerns are factors expected to restrain the growth of this market during the forecast period.
“Software segment is expected to grow at the highest rate from 2023 to 2028”
By component, the clinical decision support systems market is divided into services, software, and hardware. The services segment accounted for the largest share of this market in 2022 The demand for services is expected to grow rapidly in the coming years due to the introduction of complex software, integration, and software interoperability, which requires extensive training and upgrades.
“The On-premise CDSS segment is estimated to account for the largest share of the Clinical decision support systems market in 2023”
By delivery mode, the clinical decision support systems market is divided into on-premise and cloud-based modes. In 2023, the on-premise CDSS segment is projected to hold the largest share of the clinical decision support systems market.Factors such as lower capital expenses and operational costs incurred in this model, together with its scalability, flexibility, and low-cost are driving the market growth.
“In 2022, conventional CDSS segment accounted for the largest share of the global Clinical decision support systems market, by application”
By application, the clinical decision support systems market is divided into conventional CDSS and advanced CDSS. The conventional CDSS segment accounted for the largest share of the market in 2022. Factors such as healthcare organizations are adopting conventional decision support systems to provide guidance and reminders to caregivers at the point-of-care are driving the market growth.
“In 2022, Integrated CDSS segment accounted for the largest share of the global Clinical decision support systems market”
By product, the clinical decision support systems market is divided into integrated CDSS and standalone CDSS. The integrated CDSS segment accounted for the largest share of the market in 2022. The large share of this segment can be attributed to the reduce medication errors by healthcare providers and increased usage of integrated CDSS to improve the health outcomes and quality of care .
“The therapeutic CDSS segment is expected to grow with the highest CAGR from 2023 to 2028”
By type, the clinical decision support systems market is divided into therapeutic CDSS and diagnostic CDSS. The therapeutic CDSS segment dominated this market in 2022 This highest growth rate of this segment can be attributed to factors such as as therapeutic CDSS is equipped with a high computational capacity and a wealth of medical knowledge, making it plausible for clinicians to make informed therapeutic decisions (based on patient-specific medical facts).
“Knowledge-based CDSS segment accounted for the largest share of the global Clinical decision support systems market, by model”
The clinical decision support systems market is categorized into two main models: knowledge-based CDSS and non-knowledge-based CDSS. In 2022, the knowledge-based CDSS segment held the largest market share. This particular segment is projected to experience substantial growth throughout the forecast period. This growth can be attributed to the escalating need for personalized and evidence-based medicine, alongside the growing prevalence of chronic ailments.
“The Active CDSS segment is expected to grow with the highest CAGR during the forecast period”
The clinical decision support systems market can be categorized based on interactivity level into active CDSS and passive CDSS. In 2022, the active CDSS segment dominated the market share, and it is anticipated to exhibit the most rapid growth rate during the forecast period. Strong governmental efforts aimed at fostering clinical IT solutions, including EHR, CDSS, and CPOE, along with the increasing imperative to control healthcare expenditures, contribute to the advancement of this specific market segment.
“Inpatient settings accounted for the largest share of the global Clinical decision support systems market in 2022”
In terms of setting, the clinical decision support systems market is categorized into inpatient and ambulatory care settings. In 2022, the inpatient settings dominated the CDSS market share. This dominance can be attributed to the substantial accumulation and analysis of extensive patient data within inpatient settings, consequently driving the heightened uptake of integrated healthcare IT modules.
“North America to dominate the Clinical decision support systems market in 2023”
North America accounted for the largest share of the global clinical decision support systems market in 2022.
Elements including the existence of major industry participants, regulatory directives that support CDSS adoption, and the rise in medication errors in the US and Canada contribute to these trends.
Forecasts indicate that the Asia Pacific region will witness the most significant compound annual growth rate (CAGR) throughout the projected timeframe. This is due to factors such as the escalating prevalence of chronic illnesses and the growing attention of diverse market stakeholders toward emerging Asian nations. These factors are anticipated to propel the expansion of the clinical decision support systems market in the Asia Pacific region.
Breakdown of supply-side primary interviews, by company type, designation, and region:
Research Coverage
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
However, high investment requirements for the implementation of CDSS and inadequate interoperability coupled with rising data security concerns are factors expected to restrain the growth of this market during the forecast period.
“Software segment is expected to grow at the highest rate from 2023 to 2028”
By component, the clinical decision support systems market is divided into services, software, and hardware. The services segment accounted for the largest share of this market in 2022 The demand for services is expected to grow rapidly in the coming years due to the introduction of complex software, integration, and software interoperability, which requires extensive training and upgrades.
“The On-premise CDSS segment is estimated to account for the largest share of the Clinical decision support systems market in 2023”
By delivery mode, the clinical decision support systems market is divided into on-premise and cloud-based modes. In 2023, the on-premise CDSS segment is projected to hold the largest share of the clinical decision support systems market.Factors such as lower capital expenses and operational costs incurred in this model, together with its scalability, flexibility, and low-cost are driving the market growth.
“In 2022, conventional CDSS segment accounted for the largest share of the global Clinical decision support systems market, by application”
By application, the clinical decision support systems market is divided into conventional CDSS and advanced CDSS. The conventional CDSS segment accounted for the largest share of the market in 2022. Factors such as healthcare organizations are adopting conventional decision support systems to provide guidance and reminders to caregivers at the point-of-care are driving the market growth.
“In 2022, Integrated CDSS segment accounted for the largest share of the global Clinical decision support systems market”
By product, the clinical decision support systems market is divided into integrated CDSS and standalone CDSS. The integrated CDSS segment accounted for the largest share of the market in 2022. The large share of this segment can be attributed to the reduce medication errors by healthcare providers and increased usage of integrated CDSS to improve the health outcomes and quality of care .
“The therapeutic CDSS segment is expected to grow with the highest CAGR from 2023 to 2028”
By type, the clinical decision support systems market is divided into therapeutic CDSS and diagnostic CDSS. The therapeutic CDSS segment dominated this market in 2022 This highest growth rate of this segment can be attributed to factors such as as therapeutic CDSS is equipped with a high computational capacity and a wealth of medical knowledge, making it plausible for clinicians to make informed therapeutic decisions (based on patient-specific medical facts).
“Knowledge-based CDSS segment accounted for the largest share of the global Clinical decision support systems market, by model”
The clinical decision support systems market is categorized into two main models: knowledge-based CDSS and non-knowledge-based CDSS. In 2022, the knowledge-based CDSS segment held the largest market share. This particular segment is projected to experience substantial growth throughout the forecast period. This growth can be attributed to the escalating need for personalized and evidence-based medicine, alongside the growing prevalence of chronic ailments.
“The Active CDSS segment is expected to grow with the highest CAGR during the forecast period”
The clinical decision support systems market can be categorized based on interactivity level into active CDSS and passive CDSS. In 2022, the active CDSS segment dominated the market share, and it is anticipated to exhibit the most rapid growth rate during the forecast period. Strong governmental efforts aimed at fostering clinical IT solutions, including EHR, CDSS, and CPOE, along with the increasing imperative to control healthcare expenditures, contribute to the advancement of this specific market segment.
“Inpatient settings accounted for the largest share of the global Clinical decision support systems market in 2022”
In terms of setting, the clinical decision support systems market is categorized into inpatient and ambulatory care settings. In 2022, the inpatient settings dominated the CDSS market share. This dominance can be attributed to the substantial accumulation and analysis of extensive patient data within inpatient settings, consequently driving the heightened uptake of integrated healthcare IT modules.
“North America to dominate the Clinical decision support systems market in 2023”
North America accounted for the largest share of the global clinical decision support systems market in 2022.
Elements including the existence of major industry participants, regulatory directives that support CDSS adoption, and the rise in medication errors in the US and Canada contribute to these trends.
Forecasts indicate that the Asia Pacific region will witness the most significant compound annual growth rate (CAGR) throughout the projected timeframe. This is due to factors such as the escalating prevalence of chronic illnesses and the growing attention of diverse market stakeholders toward emerging Asian nations. These factors are anticipated to propel the expansion of the clinical decision support systems market in the Asia Pacific region.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (45%), Tier 2 (35%), and Tier 3 (20%)
- By Designation: C-level (26%), Director-level (17%), and Others (57%)
- By Region: North America (40%), Europe (20%), Asia Pacific (30%), and Latin America (6%), MEA(4%)
Research Coverage
- The report studies the Clinical decision support systems market based on component, delivery mode, product, model, interactivity level, application, setting, type, and region
- The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
- The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total Clinical decision support systems market
- The report forecasts the revenue of market segments with respect to four major regions
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Analysis of key drivers (implementation of government regulations & initiatives to promote the adoption of HCIT solutions, increasing adoption of cdss-enabled ehrs,growing collaborations & partnerships between stakeholders, growing incidence of medication errors ,development of big data and mhealth tools), restraints (data security concerns related to cloud-based cdss, inadequate interoperability), opportunities (growth potential of emerging markets, social media integration and rising technological advancements), challenges (requirement of high investments for the implementation of CDSS infrastructure ,shortage of skilled IT professionals in the healthcare industry).
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global Clinical decision support systems Market. The report analyzes this market by component, delivery mode, product, model, interactivity level, application, setting, type.
- Service Enhancement/Innovation: Detailed insights on upcoming trends in the global Clinical decision support systems
- Market Development: Comprehensive information on the lucrative emerging markets by component, delivery mode, product, model, interactivity level, application, setting, type.
- Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global Clinical decision support systems Market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Clinical decision support systems Market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 CDSS MARKET SEGMENTATION
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 MAJOR STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 HYPOTHESIS BUILDING
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.3.1 APPROACH 1: REVENUE SHARE ANALYSIS
FIGURE 6 RESEARCH METHODOLOGY: MARKET ESTIMATION
2.3.2 APPROACH 2: DEMAND-SIDE ANALYSIS
FIGURE 7 APPROACH 2: DEMAND SIDE ANALYSIS
2.3.3 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION
FIGURE 8 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET: CAGR PROJECTION ANALYSIS
2.4 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT ANALYSIS
2.7 LIMITATIONS
2.7.1 SCOPE-RELATED LIMITATIONS
2.7.2 METHODOLOGY-RELATED LIMITATIONS
2.8 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION)
FIGURE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2023 VS. 2028 (USD MILLION)
FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2023 VS. 2028 (USD MILLION)
FIGURE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2023 VS. 2028 (USD MILLION)
FIGURE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2023 VS. 2028 (USD MILLION)
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF CLINICAL DECISION SUPPORT SYSTEMS MARKET
4 PREMIUM INSIGHTS
4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW
FIGURE 21 INCREASING GOVERNMENT REGULATIONS FOR IMPLEMENTATION OF HCIT SOLUTIONS TO DRIVE MARKET
4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT AND COUNTRY
FIGURE 22 INTEGRATED CDSS SEGMENT DOMINATED US MARKET IN 2022
4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 23 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL MIX
FIGURE 24 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.5 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing government regulations for implementation of HCIT solutions
5.2.1.2 Growing adoption of CDSS-enabled EHRs
5.2.1.3 Rising incidence of medication errors
5.2.2 RESTRAINTS
5.2.2.1 Data security concerns in cloud-based CDSS
5.2.2.2 Inadequate interoperability for patient management solutions
5.2.3 OPPORTUNITIES
5.2.3.1 Development of big data and mHealth tools
5.2.3.2 High growth potential of emerging economies
5.2.3.3 Rising technological advancements
5.2.4 CHALLENGES
5.2.4.1 High capital investments for CDSS infrastructure
5.2.4.2 Shortage of skilled IT professionals
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 27 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR CLINICAL DECISION SUPPORT SYSTEMS MARKET
5.4 VALUE CHAIN ANALYSIS
FIGURE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET: VALUE CHAIN ANALYSIS
5.5 CASE STUDY ANALYSIS
5.5.1 IMPROVING PATIENT OUTCOMES
TABLE 2 CASE 1: RISING FOCUS ON IMPROVING PATIENT SAFETY
5.5.2 KNOWLEDGE ANALYZER DELIVERS ADVANCED CLINICAL EXPERIENCE
TABLE 3 CASE 2: RISING NEED TO STREAMLINE PATIENT OUTCOMES
5.5.3 ENHANCING PHYSICIAN EFFICIENCY
TABLE 4 CASE 3: RISING NEED TO IMPROVE RESPONSE TIME AND PHYSICIAN EFFICIENCY IN HEALTHCARE FACILITIES
5.5.4 INCREASING EFFICIENCY AND HEALTHCARE OUTCOMES WITH AI
TABLE 5 CASE 4: RISING FOCUS ON ENHANCING EFFICIENCY AND VALUE-BASED CARE WITH AI-POWERED CDSS
5.6 ECOSYSTEM ANALYSIS
FIGURE 29 CLINICAL DECISION SUPPORT SYSTEM MARKET: ECOSYSTEM ANALYSIS
5.7 TECHNOLOGY ANALYSIS
TABLE 6 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
5.8 TARIFF AND REGULATORY ANALYSIS
5.8.1 TARIFF FOR CDSS HARDWARE
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.3 NORTH AMERICA
5.8.3.1 Federal Food, Drug, and Cosmetic Act (FD&C Act)
5.8.3.2 Health Insurance Portability and Accountability Act (HIPAA)
5.8.3.3 Affordable Care Act, 2010
5.8.3.4 Health Information Technology for Economic and Clinical Health Act, 2009 (HITECH)
5.8.3.5 Consumer Privacy Protection Act, 2017
5.8.4 EUROPE
5.8.4.1 General Data Protection Regulation (GDPR), European Union (EU)
5.8.4.2 EU Cybersecurity Act
5.8.5 ASIA PACIFIC
5.8.5.1 China’s Cyber Security Law (CSL)
5.8.6 REST OF THE WORLD
5.8.6.1 Protection of Personal Information Act
5.8.6.2 Private cloud computing regulatory framework
5.9 PORTER'S FIVE FORCES ANALYSIS
TABLE 11 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 INDUSTRY TRENDS
5.10.1 GROWING APPLICATIONS OF AI IN CDSS
5.10.2 INCREASING FOCUS ON MOBILE & CLOUD-BASED SOLUTIONS
5.10.3 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS
5.10.4 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
5.10.5 INCREASING DEMAND FOR VALUE-BASED HEALTHCARE
5.11 BUSINESS MODELS
FIGURE 30 BENEFITS OF HYBRID BUSINESS MODELS
5.12 PRICING ANALYSIS
5.12.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
FIGURE 31 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.12.2 AVERAGE SELLING PRICE TREND, BY REGION
TABLE 12 AVERAGE SELLING PRICE TREND, BY REGION
5.13 PATENT ANALYSIS
5.13.1 PATENT PUBLICATION TRENDS FOR CLINICAL DECISION SUPPORT SYSTEMS
FIGURE 32 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2023)
5.13.2 INSIGHTS INTO JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 33 CLINICAL DECISION SUPPORT SYSTEMS MARKET: TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATENTS (JANUARY 2011–AUGUST 2023)
5.13.3 LIST OF PATENTS/PATENT APPLICATIONS FOR CDSS
5.14 KEY CONFERENCES AND EVENTS
TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS: DETAILED LIST OF CONFERENCES AND EVENTS (2023–2024)
5.15 TRADE ANALYSIS
5.15.1 TRADE ANALYSIS FOR CLINICAL DECISION SUPPORT SYSTEM HARDWARE
FIGURE 34 IMPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND)
FIGURE 35 EXPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND)
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%)
5.16.2 BUYING CRITERIA
FIGURE 37 CLINICAL DECISION SUPPORT SYSTEMS: KEY BUYING CRITERIA, BY COMPONENT
TABLE 15 BUYING CRITERIA FOR COMPONENTS, BY RANK
6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT
6.1 INTRODUCTION
TABLE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
6.2 SERVICES
6.2.1 RECURRING REQUIREMENT TO DRIVE MARKET
TABLE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 SOFTWARE
6.3.1 USE OF EMR-/EHR-INTEGRATED CDSS TO PROPEL MARKET
TABLE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 HARDWARE
6.4.1 FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH
TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)
7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT
7.1 INTRODUCTION
TABLE 20 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
7.2 INTEGRATED CDSS
7.2.1 INTEGRATION WITH EHRS AND RAPID ACCESS TO PATIENT RECORDS TO DRIVE MARKET
TABLE 21 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 STANDALONE CDSS
7.3.1 INTEROPERABILITY ISSUES WITH CPOE AND EHR TO RESTRAIN MARKET
TABLE 22 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE
8.1 INTRODUCTION
TABLE 23 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
8.2 THERAPEUTIC CDSS
8.2.1 SEAMLESS INTEGRATION INTO CLINICAL WORKFLOWS TO DRIVE MARKET
TABLE 24 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 DIAGNOSTIC CDSS
8.3.1 USE OF ALGORITHMS FOR EFFECTIVE REAL-TIME DIAGNOSIS TO SUPPORT MARKET GROWTH
TABLE 25 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL
9.1 INTRODUCTION
TABLE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
9.2 KNOWLEDGE-BASED CDSS
9.2.1 DEPLOYS CONDITIONAL LOGIC FOR DECISION-MAKING AND PROBLEM ANALYSIS
TABLE 27 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 NON-KNOWLEDGE-BASED CDSS
9.3.1 IMPLEMENTS ML AND AI TO EXPAND USER-DEFINED KNOWLEDGE BASE
TABLE 28 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE
10.1 INTRODUCTION
TABLE 29 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
10.2 ON-PREMISE CDSS
10.2.1 LOWER RISK OF DATA BREACH AND ABILITY TO CHOOSE MULTIPLE VENDORS TO DRIVE MARKET
TABLE 30 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
10.3 CLOUD-BASED CDSS
10.3.1 FLEXIBLE AND SCALABLE FEATURES TO PROPEL MARKET
TABLE 31 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION
11.1 INTRODUCTION
TABLE 32 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
11.2 CONVENTIONAL CDSS
11.2.1 ABILITY TO PROVIDE DIAGNOSTIC ASSISTANCE AND PRESCRIPTION DECISION SUPPORT TO DRIVE MARKET
TABLE 33 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
11.3 ADVANCED CDSS
11.3.1 REAL-TIME EVIDENCE AND PROTOCOL VALIDATION BENEFITS TO PROPEL MARKET
TABLE 34 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL
12.1 INTRODUCTION
TABLE 35 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
12.2 ACTIVE CDSS
12.2.1 ABILITY TO ENABLE OPTIMAL DECISION-MAKING WITH MINIMAL ERRORS TO DRIVE MARKET
TABLE 36 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
12.3 PASSIVE CDSS
12.3.1 MINIMAL DISRUPTION TO WORKFLOWS TO SUPPORT MARKET GROWTH
TABLE 37 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING
13.1 INTRODUCTION
TABLE 38 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
13.2 INPATIENT SETTINGS
13.2.1 GROWING FOCUS ON IMPROVING HEALTHCARE OPERATIONS IN HOSPITALS TO PROPEL MARKET
TABLE 39 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)
13.3 AMBULATORY CARE SETTINGS
13.3.1 RISING NEED TO CURB HEALTHCARE COSTS TO DRIVE MARKET
TABLE 40 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)
14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION
14.1 INTRODUCTION
TABLE 41 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
14.2 NORTH AMERICA
FIGURE 38 NORTH AMERICA: CDSS MARKET SNAPSHOT
TABLE 42 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 44 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 45 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 49 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 50 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.2.1 US
14.2.1.1 Growing focus on value-based care to drive market
TABLE 51 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 52 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 53 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 54 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 55 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 56 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 57 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 58 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.2.2 CANADA
14.2.2.1 Rising need to curb healthcare costs to propel market
TABLE 59 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 60 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 61 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 62 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 64 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 65 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 66 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.2.3 NORTH AMERICA: RECESSION IMPACT
14.3 EUROPE
TABLE 67 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 69 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 71 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 72 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 73 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 75 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.1 GERMANY
14.3.1.1 Favorable government support for adoption of EMRs to propel market
TABLE 76 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 77 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 78 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 79 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 80 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 81 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 82 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 83 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.2 UK
14.3.2.1 Rising establishment of healthcare facilities to fuel market
TABLE 84 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 85 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 86 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 87 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 88 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 89 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 90 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 91 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.3 FRANCE
14.3.3.1 Robust interoperability for EHR systems to drive market
TABLE 92 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 93 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 94 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 95 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 96 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 97 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 98 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 99 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.4 ITALY
14.3.4.1 Rising need for evidence-based CDSS to drive market
TABLE 100 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 101 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 102 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 103 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 105 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 106 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 107 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.5 SPAIN
14.3.5.1 Growing focus on improving patient outcomes to support market growth
TABLE 108 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 109 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 110 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 111 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 112 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 113 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 114 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 115 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.6 REST OF EUROPE
TABLE 116 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 117 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 118 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 119 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 121 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 122 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 123 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.7 EUROPE: RECESSION IMPACT
14.4 ASIA PACIFIC
FIGURE 39 ASIA PACIFIC: CDSS MARKET SNAPSHOT
TABLE 124 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 125 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 126 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 127 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 128 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 129 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 130 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 131 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 132 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.4.1 JAPAN
14.4.1.1 Rising need to digitize patient records to propel market
TABLE 133 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 134 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 135 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 136 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 138 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 139 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 140 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.4.2 CHINA
14.4.2.1 Established healthcare reforms for EMR solutions to drive market
TABLE 141 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 142 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 143 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 144 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 146 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 147 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 148 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.4.3 INDIA
14.4.3.1 Rising adoption of telemedicine to support market growth
TABLE 149 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 150 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 151 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 152 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 153 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 154 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 155 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 156 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.4.4 REST OF ASIA PACIFIC
TABLE 157 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 158 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 159 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 160 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 162 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 163 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 164 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.4.5 ASIA PACIFIC: RECESSION IMPACT
14.5 REST OF THE WORLD
TABLE 165 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 166 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 167 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 168 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 169 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 170 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 171 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 172 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 173 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.5.1 LATIN AMERICA
14.5.1.1 Developments in healthcare infrastructure to support market growth
TABLE 174 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 175 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 176 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 177 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 178 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 179 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 180 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 181 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.5.2 MIDDLE EAST & AFRICA
14.5.2.1 Increasing investments in HCIT solutions to propel market
TABLE 182 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 183 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 184 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 185 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 186 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 187 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 188 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 189 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.5.3 REST OF THE WORLD: RECESSION IMPACT
15 COMPETITIVE LANDSCAPE
15.1 OVERVIEW
15.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 190 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
15.3 REVENUE SHARE ANALYSIS OF LEADING MARKET PLAYERS
FIGURE 40 REVENUE SHARE ANALYSIS OF KEY PLAYERS
15.4 MARKET SHARE ANALYSIS
FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
15.5 COMPANY EVALUATION MATRIX
15.5.1 STARS
15.5.2 EMERGING LEADERS
15.5.3 PERVASIVE PLAYERS
15.5.4 PARTICIPANTS
15.5.5 COMPANY FOOTPRINT
TABLE 191 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY FOOTPRINT OF KEY PLAYERS
TABLE 192 CLINICAL DECISION SUPPORT SYSTEMS MARKET: APPLICATION & PRODUCT FOOTPRINT OF KEY PLAYERS
TABLE 193 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL FOOTPRINT OF KEY PLAYERS
FIGURE 42 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY EVALUATION MATRIX (2022)
15.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES
15.6.1 PROGRESSIVE COMPANIES
15.6.2 RESPONSIVE COMPANIES
15.6.3 DYNAMIC COMPANIES
15.6.4 STARTING BLOCKS
FIGURE 43 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
15.6.4.1 COMPETITIVE BENCHMARKING
TABLE 194 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 195 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)
15.7 COMPETITIVE SITUATIONS AND TRENDS
TABLE 196 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS (JANUARY 2020–AUGUST 2023)
15.7.1 DEALS
TABLE 197 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEALS (JANUARY 2020–AUGUST 2023)
15.7.2 OTHER DEVELOPMENTS
TABLE 198 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OTHER DEVELOPMENTS (JANUARY 2020–AUGUST 2023)
16 COMPANY PROFILES
16.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
16.1.1 EPIC SYSTEMS CORPORATION
TABLE 199 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
16.1.2 WOLTERS KLUWER N.V.
TABLE 200 WOLTERS KLUWER N.V.: BUSINESS OVERVIEW
FIGURE 44 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT (2022)
16.1.3 ORACLE
TABLE 201 ORACLE: BUSINESS OVERVIEW
FIGURE 45 ORACLE: COMPANY SNAPSHOT (2023)
16.1.4 MERATIVE
TABLE 202 MERATIVE: BUSINESS OVERVIEW
16.1.5 VERADIGM LLC
TABLE 203 VERADIGM LLC: BUSINESS OVERVIEW
FIGURE 46 VERADIGM LLC: COMPANY SNAPSHOT (2021)
16.1.6 CHANGE HEALTHCARE (PART OF OPTUM)
FIGURE 47 OPTUM.: COMPANY SNAPSHOT (2022)
16.1.7 ATHENAHEALTH
TABLE 205 ATHENA HEALTH: BUSINESS OVERVIEW
16.1.8 ELSEVIER (DIVISION OF RELX GROUP)
TABLE 206 ELSEVIER: BUSINESS OVERVIEW
16.1.9 ZYNX HEALTH INCORPORATED
TABLE 207 ZYNX HEALTH INCORPORATED: BUSINESS OVERVIEW
16.1.10 KONINKLIJKE PHILIPS N.V.
TABLE 208 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 48 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
16.1.11 MEDICAL INFORMATION TECHNOLOGY, INC.
TABLE 209 MEDICAL INFORMATION TECHNOLOGY, INC.: BUSINESS OVERVIEW
16.1.12 NEXTGEN HEALTHCARE, INC.
TABLE 210 NEXTGEN HEALTHCARE, INC.: BUSINESS OVERVIEW
FIGURE 49 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2022)
16.1.13 CUREMD HEALTHCARE
TABLE 211 CUREMD HEALTHCARE: BUSINESS OVERVIEW
16.1.14 SIEMENS HEALTHINEERS
TABLE 212 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
FIGURE 50 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
16.1.15 EBSCO INFORMATION SERVICES
TABLE 213 EBSCO INFORMATION SERVICES: BUSINESS OVERVIEW
16.1.16 GE HEALTHCARE
TABLE 214 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
16.1.17 ECLINICALWORKS, LLC
TABLE 215 ECLINICALWORKS, LLC: BUSINESS OVERVIEW
16.1.18 THE MEDICAL ALGORITHMS COMPANY LIMITED
TABLE 216 THE MEDICAL ALGORITHMS COMPANY LIMITED: BUSINESS OVERVIEW
16.1.19 HERA-MI
TABLE 217 HERA-MI: BUSINESS OVERVIEW
16.1.20 RAMPMEDICAL
TABLE 218 RAMPMEDICAL: BUSINESS OVERVIEW
16.2 OTHER PLAYERS
16.2.1 CARECLOUD, INC.
16.2.2 VISUALDX
16.2.3 STANSON HEALTH (PART OF PREMIER, INC.)
16.2.4 FIRST DATABANK, INC.
16.2.5 STRATA DECISION TECHNOLOGY
16.2.6 ALCIDION
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
17 APPENDIX
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 CDSS MARKET SEGMENTATION
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 MAJOR STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 HYPOTHESIS BUILDING
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.3.1 APPROACH 1: REVENUE SHARE ANALYSIS
FIGURE 6 RESEARCH METHODOLOGY: MARKET ESTIMATION
2.3.2 APPROACH 2: DEMAND-SIDE ANALYSIS
FIGURE 7 APPROACH 2: DEMAND SIDE ANALYSIS
2.3.3 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION
FIGURE 8 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET: CAGR PROJECTION ANALYSIS
2.4 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT ANALYSIS
2.7 LIMITATIONS
2.7.1 SCOPE-RELATED LIMITATIONS
2.7.2 METHODOLOGY-RELATED LIMITATIONS
2.8 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION)
FIGURE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2023 VS. 2028 (USD MILLION)
FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2023 VS. 2028 (USD MILLION)
FIGURE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2023 VS. 2028 (USD MILLION)
FIGURE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2023 VS. 2028 (USD MILLION)
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF CLINICAL DECISION SUPPORT SYSTEMS MARKET
4 PREMIUM INSIGHTS
4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW
FIGURE 21 INCREASING GOVERNMENT REGULATIONS FOR IMPLEMENTATION OF HCIT SOLUTIONS TO DRIVE MARKET
4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT AND COUNTRY
FIGURE 22 INTEGRATED CDSS SEGMENT DOMINATED US MARKET IN 2022
4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 23 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL MIX
FIGURE 24 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.5 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing government regulations for implementation of HCIT solutions
5.2.1.2 Growing adoption of CDSS-enabled EHRs
5.2.1.3 Rising incidence of medication errors
5.2.2 RESTRAINTS
5.2.2.1 Data security concerns in cloud-based CDSS
5.2.2.2 Inadequate interoperability for patient management solutions
5.2.3 OPPORTUNITIES
5.2.3.1 Development of big data and mHealth tools
5.2.3.2 High growth potential of emerging economies
5.2.3.3 Rising technological advancements
5.2.4 CHALLENGES
5.2.4.1 High capital investments for CDSS infrastructure
5.2.4.2 Shortage of skilled IT professionals
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 27 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR CLINICAL DECISION SUPPORT SYSTEMS MARKET
5.4 VALUE CHAIN ANALYSIS
FIGURE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET: VALUE CHAIN ANALYSIS
5.5 CASE STUDY ANALYSIS
5.5.1 IMPROVING PATIENT OUTCOMES
TABLE 2 CASE 1: RISING FOCUS ON IMPROVING PATIENT SAFETY
5.5.2 KNOWLEDGE ANALYZER DELIVERS ADVANCED CLINICAL EXPERIENCE
TABLE 3 CASE 2: RISING NEED TO STREAMLINE PATIENT OUTCOMES
5.5.3 ENHANCING PHYSICIAN EFFICIENCY
TABLE 4 CASE 3: RISING NEED TO IMPROVE RESPONSE TIME AND PHYSICIAN EFFICIENCY IN HEALTHCARE FACILITIES
5.5.4 INCREASING EFFICIENCY AND HEALTHCARE OUTCOMES WITH AI
TABLE 5 CASE 4: RISING FOCUS ON ENHANCING EFFICIENCY AND VALUE-BASED CARE WITH AI-POWERED CDSS
5.6 ECOSYSTEM ANALYSIS
FIGURE 29 CLINICAL DECISION SUPPORT SYSTEM MARKET: ECOSYSTEM ANALYSIS
5.7 TECHNOLOGY ANALYSIS
TABLE 6 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
5.8 TARIFF AND REGULATORY ANALYSIS
5.8.1 TARIFF FOR CDSS HARDWARE
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.3 NORTH AMERICA
5.8.3.1 Federal Food, Drug, and Cosmetic Act (FD&C Act)
5.8.3.2 Health Insurance Portability and Accountability Act (HIPAA)
5.8.3.3 Affordable Care Act, 2010
5.8.3.4 Health Information Technology for Economic and Clinical Health Act, 2009 (HITECH)
5.8.3.5 Consumer Privacy Protection Act, 2017
5.8.4 EUROPE
5.8.4.1 General Data Protection Regulation (GDPR), European Union (EU)
5.8.4.2 EU Cybersecurity Act
5.8.5 ASIA PACIFIC
5.8.5.1 China’s Cyber Security Law (CSL)
5.8.6 REST OF THE WORLD
5.8.6.1 Protection of Personal Information Act
5.8.6.2 Private cloud computing regulatory framework
5.9 PORTER'S FIVE FORCES ANALYSIS
TABLE 11 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 INDUSTRY TRENDS
5.10.1 GROWING APPLICATIONS OF AI IN CDSS
5.10.2 INCREASING FOCUS ON MOBILE & CLOUD-BASED SOLUTIONS
5.10.3 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS
5.10.4 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
5.10.5 INCREASING DEMAND FOR VALUE-BASED HEALTHCARE
5.11 BUSINESS MODELS
FIGURE 30 BENEFITS OF HYBRID BUSINESS MODELS
5.12 PRICING ANALYSIS
5.12.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
FIGURE 31 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.12.2 AVERAGE SELLING PRICE TREND, BY REGION
TABLE 12 AVERAGE SELLING PRICE TREND, BY REGION
5.13 PATENT ANALYSIS
5.13.1 PATENT PUBLICATION TRENDS FOR CLINICAL DECISION SUPPORT SYSTEMS
FIGURE 32 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2023)
5.13.2 INSIGHTS INTO JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 33 CLINICAL DECISION SUPPORT SYSTEMS MARKET: TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATENTS (JANUARY 2011–AUGUST 2023)
5.13.3 LIST OF PATENTS/PATENT APPLICATIONS FOR CDSS
5.14 KEY CONFERENCES AND EVENTS
TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS: DETAILED LIST OF CONFERENCES AND EVENTS (2023–2024)
5.15 TRADE ANALYSIS
5.15.1 TRADE ANALYSIS FOR CLINICAL DECISION SUPPORT SYSTEM HARDWARE
FIGURE 34 IMPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND)
FIGURE 35 EXPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND)
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%)
5.16.2 BUYING CRITERIA
FIGURE 37 CLINICAL DECISION SUPPORT SYSTEMS: KEY BUYING CRITERIA, BY COMPONENT
TABLE 15 BUYING CRITERIA FOR COMPONENTS, BY RANK
6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT
6.1 INTRODUCTION
TABLE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
6.2 SERVICES
6.2.1 RECURRING REQUIREMENT TO DRIVE MARKET
TABLE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 SOFTWARE
6.3.1 USE OF EMR-/EHR-INTEGRATED CDSS TO PROPEL MARKET
TABLE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 HARDWARE
6.4.1 FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH
TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)
7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT
7.1 INTRODUCTION
TABLE 20 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
7.2 INTEGRATED CDSS
7.2.1 INTEGRATION WITH EHRS AND RAPID ACCESS TO PATIENT RECORDS TO DRIVE MARKET
TABLE 21 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 STANDALONE CDSS
7.3.1 INTEROPERABILITY ISSUES WITH CPOE AND EHR TO RESTRAIN MARKET
TABLE 22 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE
8.1 INTRODUCTION
TABLE 23 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
8.2 THERAPEUTIC CDSS
8.2.1 SEAMLESS INTEGRATION INTO CLINICAL WORKFLOWS TO DRIVE MARKET
TABLE 24 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 DIAGNOSTIC CDSS
8.3.1 USE OF ALGORITHMS FOR EFFECTIVE REAL-TIME DIAGNOSIS TO SUPPORT MARKET GROWTH
TABLE 25 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL
9.1 INTRODUCTION
TABLE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
9.2 KNOWLEDGE-BASED CDSS
9.2.1 DEPLOYS CONDITIONAL LOGIC FOR DECISION-MAKING AND PROBLEM ANALYSIS
TABLE 27 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 NON-KNOWLEDGE-BASED CDSS
9.3.1 IMPLEMENTS ML AND AI TO EXPAND USER-DEFINED KNOWLEDGE BASE
TABLE 28 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE
10.1 INTRODUCTION
TABLE 29 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
10.2 ON-PREMISE CDSS
10.2.1 LOWER RISK OF DATA BREACH AND ABILITY TO CHOOSE MULTIPLE VENDORS TO DRIVE MARKET
TABLE 30 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
10.3 CLOUD-BASED CDSS
10.3.1 FLEXIBLE AND SCALABLE FEATURES TO PROPEL MARKET
TABLE 31 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION
11.1 INTRODUCTION
TABLE 32 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
11.2 CONVENTIONAL CDSS
11.2.1 ABILITY TO PROVIDE DIAGNOSTIC ASSISTANCE AND PRESCRIPTION DECISION SUPPORT TO DRIVE MARKET
TABLE 33 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
11.3 ADVANCED CDSS
11.3.1 REAL-TIME EVIDENCE AND PROTOCOL VALIDATION BENEFITS TO PROPEL MARKET
TABLE 34 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL
12.1 INTRODUCTION
TABLE 35 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
12.2 ACTIVE CDSS
12.2.1 ABILITY TO ENABLE OPTIMAL DECISION-MAKING WITH MINIMAL ERRORS TO DRIVE MARKET
TABLE 36 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
12.3 PASSIVE CDSS
12.3.1 MINIMAL DISRUPTION TO WORKFLOWS TO SUPPORT MARKET GROWTH
TABLE 37 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING
13.1 INTRODUCTION
TABLE 38 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
13.2 INPATIENT SETTINGS
13.2.1 GROWING FOCUS ON IMPROVING HEALTHCARE OPERATIONS IN HOSPITALS TO PROPEL MARKET
TABLE 39 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)
13.3 AMBULATORY CARE SETTINGS
13.3.1 RISING NEED TO CURB HEALTHCARE COSTS TO DRIVE MARKET
TABLE 40 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)
14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION
14.1 INTRODUCTION
TABLE 41 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
14.2 NORTH AMERICA
FIGURE 38 NORTH AMERICA: CDSS MARKET SNAPSHOT
TABLE 42 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 44 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 45 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 49 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 50 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.2.1 US
14.2.1.1 Growing focus on value-based care to drive market
TABLE 51 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 52 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 53 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 54 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 55 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 56 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 57 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 58 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.2.2 CANADA
14.2.2.1 Rising need to curb healthcare costs to propel market
TABLE 59 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 60 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 61 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 62 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 64 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 65 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 66 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.2.3 NORTH AMERICA: RECESSION IMPACT
14.3 EUROPE
TABLE 67 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 69 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 71 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 72 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 73 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 75 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.1 GERMANY
14.3.1.1 Favorable government support for adoption of EMRs to propel market
TABLE 76 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 77 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 78 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 79 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 80 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 81 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 82 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 83 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.2 UK
14.3.2.1 Rising establishment of healthcare facilities to fuel market
TABLE 84 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 85 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 86 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 87 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 88 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 89 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 90 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 91 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.3 FRANCE
14.3.3.1 Robust interoperability for EHR systems to drive market
TABLE 92 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 93 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 94 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 95 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 96 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 97 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 98 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 99 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.4 ITALY
14.3.4.1 Rising need for evidence-based CDSS to drive market
TABLE 100 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 101 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 102 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 103 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 105 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 106 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 107 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.5 SPAIN
14.3.5.1 Growing focus on improving patient outcomes to support market growth
TABLE 108 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 109 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 110 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 111 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 112 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 113 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 114 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 115 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.6 REST OF EUROPE
TABLE 116 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 117 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 118 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 119 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 121 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 122 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 123 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.3.7 EUROPE: RECESSION IMPACT
14.4 ASIA PACIFIC
FIGURE 39 ASIA PACIFIC: CDSS MARKET SNAPSHOT
TABLE 124 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 125 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 126 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 127 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 128 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 129 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 130 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 131 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 132 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.4.1 JAPAN
14.4.1.1 Rising need to digitize patient records to propel market
TABLE 133 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 134 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 135 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 136 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 138 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 139 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 140 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.4.2 CHINA
14.4.2.1 Established healthcare reforms for EMR solutions to drive market
TABLE 141 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 142 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 143 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 144 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 146 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 147 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 148 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.4.3 INDIA
14.4.3.1 Rising adoption of telemedicine to support market growth
TABLE 149 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 150 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 151 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 152 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 153 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 154 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 155 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 156 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.4.4 REST OF ASIA PACIFIC
TABLE 157 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 158 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 159 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 160 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 162 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 163 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 164 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.4.5 ASIA PACIFIC: RECESSION IMPACT
14.5 REST OF THE WORLD
TABLE 165 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 166 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 167 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 168 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 169 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 170 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 171 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 172 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 173 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.5.1 LATIN AMERICA
14.5.1.1 Developments in healthcare infrastructure to support market growth
TABLE 174 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 175 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 176 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 177 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 178 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 179 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 180 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 181 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.5.2 MIDDLE EAST & AFRICA
14.5.2.1 Increasing investments in HCIT solutions to propel market
TABLE 182 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 183 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
TABLE 184 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 185 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 186 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
TABLE 187 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
TABLE 188 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 189 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
14.5.3 REST OF THE WORLD: RECESSION IMPACT
15 COMPETITIVE LANDSCAPE
15.1 OVERVIEW
15.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 190 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
15.3 REVENUE SHARE ANALYSIS OF LEADING MARKET PLAYERS
FIGURE 40 REVENUE SHARE ANALYSIS OF KEY PLAYERS
15.4 MARKET SHARE ANALYSIS
FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
15.5 COMPANY EVALUATION MATRIX
15.5.1 STARS
15.5.2 EMERGING LEADERS
15.5.3 PERVASIVE PLAYERS
15.5.4 PARTICIPANTS
15.5.5 COMPANY FOOTPRINT
TABLE 191 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY FOOTPRINT OF KEY PLAYERS
TABLE 192 CLINICAL DECISION SUPPORT SYSTEMS MARKET: APPLICATION & PRODUCT FOOTPRINT OF KEY PLAYERS
TABLE 193 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL FOOTPRINT OF KEY PLAYERS
FIGURE 42 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY EVALUATION MATRIX (2022)
15.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES
15.6.1 PROGRESSIVE COMPANIES
15.6.2 RESPONSIVE COMPANIES
15.6.3 DYNAMIC COMPANIES
15.6.4 STARTING BLOCKS
FIGURE 43 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
15.6.4.1 COMPETITIVE BENCHMARKING
TABLE 194 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 195 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)
15.7 COMPETITIVE SITUATIONS AND TRENDS
TABLE 196 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS (JANUARY 2020–AUGUST 2023)
15.7.1 DEALS
TABLE 197 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEALS (JANUARY 2020–AUGUST 2023)
15.7.2 OTHER DEVELOPMENTS
TABLE 198 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OTHER DEVELOPMENTS (JANUARY 2020–AUGUST 2023)
16 COMPANY PROFILES
16.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
16.1.1 EPIC SYSTEMS CORPORATION
TABLE 199 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
16.1.2 WOLTERS KLUWER N.V.
TABLE 200 WOLTERS KLUWER N.V.: BUSINESS OVERVIEW
FIGURE 44 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT (2022)
16.1.3 ORACLE
TABLE 201 ORACLE: BUSINESS OVERVIEW
FIGURE 45 ORACLE: COMPANY SNAPSHOT (2023)
16.1.4 MERATIVE
TABLE 202 MERATIVE: BUSINESS OVERVIEW
16.1.5 VERADIGM LLC
TABLE 203 VERADIGM LLC: BUSINESS OVERVIEW
FIGURE 46 VERADIGM LLC: COMPANY SNAPSHOT (2021)
16.1.6 CHANGE HEALTHCARE (PART OF OPTUM)
FIGURE 47 OPTUM.: COMPANY SNAPSHOT (2022)
16.1.7 ATHENAHEALTH
TABLE 205 ATHENA HEALTH: BUSINESS OVERVIEW
16.1.8 ELSEVIER (DIVISION OF RELX GROUP)
TABLE 206 ELSEVIER: BUSINESS OVERVIEW
16.1.9 ZYNX HEALTH INCORPORATED
TABLE 207 ZYNX HEALTH INCORPORATED: BUSINESS OVERVIEW
16.1.10 KONINKLIJKE PHILIPS N.V.
TABLE 208 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 48 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
16.1.11 MEDICAL INFORMATION TECHNOLOGY, INC.
TABLE 209 MEDICAL INFORMATION TECHNOLOGY, INC.: BUSINESS OVERVIEW
16.1.12 NEXTGEN HEALTHCARE, INC.
TABLE 210 NEXTGEN HEALTHCARE, INC.: BUSINESS OVERVIEW
FIGURE 49 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2022)
16.1.13 CUREMD HEALTHCARE
TABLE 211 CUREMD HEALTHCARE: BUSINESS OVERVIEW
16.1.14 SIEMENS HEALTHINEERS
TABLE 212 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
FIGURE 50 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
16.1.15 EBSCO INFORMATION SERVICES
TABLE 213 EBSCO INFORMATION SERVICES: BUSINESS OVERVIEW
16.1.16 GE HEALTHCARE
TABLE 214 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
16.1.17 ECLINICALWORKS, LLC
TABLE 215 ECLINICALWORKS, LLC: BUSINESS OVERVIEW
16.1.18 THE MEDICAL ALGORITHMS COMPANY LIMITED
TABLE 216 THE MEDICAL ALGORITHMS COMPANY LIMITED: BUSINESS OVERVIEW
16.1.19 HERA-MI
TABLE 217 HERA-MI: BUSINESS OVERVIEW
16.1.20 RAMPMEDICAL
TABLE 218 RAMPMEDICAL: BUSINESS OVERVIEW
16.2 OTHER PLAYERS
16.2.1 CARECLOUD, INC.
16.2.2 VISUALDX
16.2.3 STANSON HEALTH (PART OF PREMIER, INC.)
16.2.4 FIRST DATABANK, INC.
16.2.5 STRATA DECISION TECHNOLOGY
16.2.6 ALCIDION
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
17 APPENDIX
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS
